ReviewPharmacological reports : PR2022

GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders.

Divya Soni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.